DocuSign, Inc. (NASDAQ:DOCU) CEO Allan C. Thygesen Sells 7,763 Shares

DocuSign, Inc. (NASDAQ:DOCU) CEO Allan C. Thygesen sold 7,763 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the transaction, the chief executive officer now owns 100,062 shares in the company, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

DocuSign Stock Up 0.2 %

Shares of DOCU opened at $80.45 on Wednesday. The firm has a market capitalization of $16.33 billion, a PE ratio of 16.97, a P/E/G ratio of 8.31 and a beta of 0.92. The firm has a 50-day moving average price of $72.86 and a 200 day moving average price of $61.36. DocuSign, Inc. has a 52-week low of $44.34 and a 52-week high of $86.75.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business had revenue of $736.03 million for the quarter, compared to analyst estimates of $727.20 million. During the same quarter last year, the business earned $0.09 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. On average, equities analysts expect that DocuSign, Inc. will post 1.03 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on DOCU. Wells Fargo & Company raised their target price on shares of DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a report on Friday, September 6th. Bank of America raised their price target on DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Jefferies Financial Group upped their price objective on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, September 6th. Finally, JMP Securities boosted their price target on shares of DocuSign from $84.00 to $108.00 and gave the company a “market outperform” rating in a report on Friday, November 22nd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and a consensus target price of $70.73.

Institutional Trading of DocuSign

Hedge funds and other institutional investors have recently modified their holdings of the company. Inspire Investing LLC bought a new stake in shares of DocuSign in the 3rd quarter worth approximately $911,000. Charles Schwab Investment Management Inc. grew its holdings in shares of DocuSign by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after acquiring an additional 16,014 shares during the last quarter. Comerica Bank raised its position in shares of DocuSign by 228.8% during the first quarter. Comerica Bank now owns 28,901 shares of the company’s stock worth $1,721,000 after purchasing an additional 20,110 shares during the period. International Assets Investment Management LLC lifted its holdings in shares of DocuSign by 5,660.8% during the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after purchasing an additional 431,295 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its position in shares of DocuSign by 7.1% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock valued at $80,501,000 after purchasing an additional 85,987 shares during the period. Institutional investors own 77.64% of the company’s stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.